Vutrisiran not checked

Alnylam · ALN-TTRSC02

FollowEvery change as it happens, and a Monday email
Stage
in the US · approved in the EU
Next date
Phase 3 trial completes
Trials
3 active
4 in total · 4 in the EU
Targets
 

What this is

How it works
A short strand of RNA that switches off one gene, so the body makes less of one protein.-siran: small interfering RNA WHO name stem
Tested for
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy (2 trials), Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy, hATTR-PN
Main trialPhase 3
“This study will evaluate the efficacy and safety of vutrisiran 25 mg administered subcutaneously (SC) once every 3 months (q3M) compared to placebo in participants with ATTR amyloidosis with cardiomyopathy.”In the company’s words, NCT04153149 on ClinicalTrials.gov
Other names
ALN-TTRSC02 · AMVUTTRA

Other drugs for Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

All 3 drugs for Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 8 May 2024 HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Phase 3Recruiting 27 Dec 2027 TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Phase 3Enrolling by invitation 31 Mar 2028 A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Phase 3Completed 10 Nov 2020 HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Vutrisiran

Following is part of Solo: you see every change to Vutrisiran the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in